Cite

HARVARD Citation

    Silva, J. et al. (2021). Disclosing the potential of eleganolone for Parkinson's disease therapeutics: Neuroprotective and anti-inflammatory activities. Pharmacological research. p. . [Online]. 
  
Back to record